Increased risk of bullous pemphigoid in dipeptidyl peptidase 4 inhibitors: A nationwide, population‐based, cohort study in Taiwan-Reference-Cited by-同舟云学术

Increased risk of bullous pemphigoid in dipeptidyl peptidase 4 inhibitors: A nationwide, population‐based, cohort study in Taiwan

Author:

Hung Chih‐Tsung¹²^ORCID,Liu Jhih‐Syuan³,Cheng Cheng‐Yi⁴,Chung Chi‐Hsiang⁵⁶,Chiang Chien‐Ping¹,Chien Wu‐Chien⁵⁷⁸,Wang Wei‐Ming¹²

Affiliation:

1. Department of Dermatology Tri‐Service General Hospital National Defense Medical Center Taipei Taiwan

2. Graduate Institute of Medical Sciences National Defense Medical Center Taipei Taiwan

3. Division of Endocrine and Metabolism Department of Internal Medicine Tri‐Service General Hospital Taipei Taiwan

4. Department of Nuclear Medicine Tri‐Service General Hospital National Defense Medical Center Taipei Taiwan

5. School of Public Health National Defense Medical Center Taipei Taiwan

6. Taiwanese Injury Prevention and Safety Promotion Association Taipei Taiwan

7. Department of Medical Research Tri‐Service General Hospital National Defense Medical Center Taipei Taiwan

8. Graduate Institute of Life Sciences National Defense Medical Center Taipei Taiwan

Funder

Tri-Service Hospital Research Foundation

Publisher

Wiley

Subject

Dermatology,General Medicine

Link

Reference31 articles.

2. Molecular heterogeneity of the bullous pemphigoid antigens as detected by immunoblotting;Labib RS;J Immunol,1986

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献